fibrinogen has been researched along with Mesothelioma in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alimohammadi, A; Arns, M; Berger, W; Brcic, L; Dome, B; Filipits, M; Ghanim, B; Grusch, M; Hegedus, B; Hoda, MA; Jakopovic, M; Klepetko, W; Klikovits, T; Laszlo, V; Samarzija, M; Schenk, P; Winter, MP | 1 |
| Aigner, C; Bendek, M; Berger, W; Brcic, L; Dome, B; Dong, Y; Frauenfelder, T; Ghanim, B; Grusch, M; Hegedus, B; Hoda, MA; Jakopovic, M; Kao, SC; Kirschner, MB; Klepetko, W; Klikovits, T; Laszlo, V; Nguyen-Kim, TD; Opitz, I; Ozsvar, J; Reid, G; Rozsas, A; Samarzija, M; Stockhammer, P; Szirtes, I; van Zandwijk, N; Weder, W | 1 |
| Emri, S; Gungen, Y; Idell, S; Johnson, AR; Kumar, A; Pueblitz, S; Shetty, S | 1 |
| Chahinian, AP; Higashino, K; Miyake, M; Nakano, T; Ninomiya, K; Shinjo, M; Togawa, N; Tonomura, A | 1 |
4 other study(ies) available for fibrinogen and Mesothelioma
| Article | Year |
|---|---|
Circulating fibrinogen is a prognostic and predictive biomarker in malignant pleural mesothelioma.
Topics: Biomarkers, Tumor; Combined Modality Therapy; Female; Fibrinogen; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Pleural Neoplasms; Prognosis; Retrospective Studies | 2014 |
Circulating activin A is a novel prognostic biomarker in malignant pleural mesothelioma - A multi-institutional study.
Topics: Activins; Aged; Biomarkers, Tumor; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Pleural Neoplasms; Prognosis | 2016 |
Fibrinogen promotes adhesion of monocytic to human mesothelioma cells.
Topics: Binding Sites; Cell Adhesion; Fibrinogen; Humans; Intercellular Adhesion Molecule-1; Mesothelioma; Pleural Neoplasms; Radioligand Assay; Tumor Cells, Cultured | 1996 |
Interleukin 6 and its relationship to clinical parameters in patients with malignant pleural mesothelioma.
Topics: Adenocarcinoma; Biomarkers, Tumor; C-Reactive Protein; Diagnosis, Differential; Fibrinogen; Humans; Interleukin-6; Lung Neoplasms; Mesothelioma; Orosomucoid; Pleural Effusion; Pleural Neoplasms; Pleurisy; Survival Analysis; Tuberculosis, Pulmonary; Tumor Necrosis Factor-alpha | 1998 |